A study to learn the effects of ripretinib (study drug) on how midazolam behaves in the body of people with advanced gastrointestinal stromal tumor

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-501477-40-00

Enrollment

Registered

2023-08-28

Start date

2024-06-25

Completion date

Unknown

Last updated

2025-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Gastrointestinal Stromal Tumor

None listed

Sex/Gender

All

Age

18 Years to No maximum

Italy, Netherlands, Spain

None listed

Source: EU CTIS · Data processed: May 30, 2026